title: Higher vitreous concentrations of dabigatran after repeated oral administration.
authors.affiliation: Rotterdam Ophthalmic Institute, Rotterdam Eye Hospital, Rotterdam, The Netherlands.
authors.forename: Verena C
authors.initials: VC
authors.lastname: Mulder
authors.affiliation: Good Biomarker Sciences, Leiden, The Netherlands.
authors.forename: Cornelis
authors.initials: C
authors.lastname: Kluft
authors.affiliation: Vitreoretinal Surgery, The Rotterdam Eye Hospital, Rotterdam, The Netherlands.
authors.forename: Peter G
authors.initials: PG
authors.lastname: van Etten
authors.affiliation: Vitreoretinal Surgery, The Rotterdam Eye Hospital, Rotterdam, The Netherlands.
authors.forename: Ellen C
authors.initials: EC
authors.lastname: La Heij
authors.affiliation: Rotterdam Ophthalmic Institute, Rotterdam Eye Hospital, Rotterdam, The Netherlands.|Vitreoretinal Surgery, The Rotterdam Eye Hospital, Rotterdam, The Netherlands.|Erasmus Medical Centre, Rotterdam, The Netherlands.
authors.forename: Jan C
authors.initials: JC
authors.lastname: van Meurs
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000991:Antithrombins / Q000008:administration & dosage / Q000493:pharmacokinetics; D001813:Blood-Retinal Barrier / Q000187:drug effects*; D000069604:Dabigatran / Q000008:administration & dosage / Q000493:pharmacokinetics*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008297:Male; D012167:Retinal Perforations / Q000188:drug therapy* / Q000378:metabolism; D014018:Tissue Distribution; D014822:Vitreous Body / Q000378:metabolism*
chemical_list: D000991:Antithrombins; D000069604:Dabigatran